» Articles » PMID: 24811753

Overview of Classical Test Theory and Item Response Theory for the Quantitative Assessment of Items in Developing Patient-reported Outcomes Measures

Overview
Journal Clin Ther
Specialty Pharmacology
Date 2014 May 10
PMID 24811753
Citations 185
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The US Food and Drug Administration's guidance for industry document on patient-reported outcomes (PRO) defines content validity as "the extent to which the instrument measures the concept of interest" (FDA, 2009, p. 12). According to Strauss and Smith (2009), construct validity "is now generally viewed as a unifying form of validity for psychological measurements, subsuming both content and criterion validity" (p. 7). Hence, both qualitative and quantitative information are essential in evaluating the validity of measures.

Methods: We review classical test theory and item response theory (IRT) approaches to evaluating PRO measures, including frequency of responses to each category of the items in a multi-item scale, the distribution of scale scores, floor and ceiling effects, the relationship between item response options and the total score, and the extent to which hypothesized "difficulty" (severity) order of items is represented by observed responses.

Results: If a researcher has few qualitative data and wants to get preliminary information about the content validity of the instrument, then descriptive assessments using classical test theory should be the first step. As the sample size grows during subsequent stages of instrument development, confidence in the numerical estimates from Rasch and other IRT models (as well as those of classical test theory) would also grow.

Conclusion: Classical test theory and IRT can be useful in providing a quantitative assessment of items and scales during the content-validity phase of PRO-measure development. Depending on the particular type of measure and the specific circumstances, the classical test theory and/or the IRT should be considered to help maximize the content validity of PRO measures.

Citing Articles

Psychometric evaluation of the unmet needs instrument for carers of people with dementia (UNI-C).

Mansfield E, Cameron E, Clapham M, Hall A, Boyes A J Patient Rep Outcomes. 2025; 9(1):28.

PMID: 40067517 PMC: 11896954. DOI: 10.1186/s41687-025-00856-7.


Development and validation of the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT), a scale for assessing public attitudes to next-generation vaccine delivery technologies.

Kantor J, Carlisle R, Vanderslott S, Pollard A, Morrison M Hum Vaccin Immunother. 2025; 21(1):2469994.

PMID: 40028861 PMC: 11881882. DOI: 10.1080/21645515.2025.2469994.


Severity Benchmarks for the Level of Personality Functioning Scale-Brief Form 2.0 (LPFS-BF 2.0) in Polish Adults.

Juras K, Mendrok M, Pach J, Moron M Healthcare (Basel). 2025; 13(3).

PMID: 39942529 PMC: 11816430. DOI: 10.3390/healthcare13030340.


Translation, cross-cultural adaptation and psychometric evaluation of the Serbian Ankylosing Spondylitis Quality of Life (ASQoL) Questionnaire (refers to r-axSpA) and its relations with disease activity and functional status indices.

Zlatkovic-Svenda M, Djokic A, Perunicic A, Zdravkovic M, Dolijanovic S, Thorpe J J Patient Rep Outcomes. 2025; 9(1):8.

PMID: 39812921 PMC: 11735697. DOI: 10.1186/s41687-025-00838-9.


Conceptualization of pain in Croatian adults: a cross-sectional and psychometric study.

Schuster S, Loncaric Kelecic I, Bilic M, Begic M, Pate J Croat Med J. 2025; 65(6):473-482.

PMID: 39812096 PMC: 11748452.


References
1.
Hays R, Bjorner J, Revicki D, Spritzer K, Cella D . Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009; 18(7):873-80. PMC: 2724630. DOI: 10.1007/s11136-009-9496-9. View

2.
Strauss M, Smith G . Construct validity: advances in theory and methodology. Annu Rev Clin Psychol. 2008; 5:1-25. PMC: 2739261. DOI: 10.1146/annurev.clinpsy.032408.153639. View

3.
Hays R, Farivar S, Liu H . Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD. 2006; 2(1):63-7. DOI: 10.1081/copd-200050663. View

4.
Patrick D, Burke L, Gwaltney C, Leidy N, Martin M, Molsen E . Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO.... Value Health. 2011; 14(8):967-77. DOI: 10.1016/j.jval.2011.06.014. View

5.
Hays R, Morales L, Reise S . Item response theory and health outcomes measurement in the 21st century. Med Care. 2000; 38(9 Suppl):II28-42. PMC: 1815384. DOI: 10.1097/00005650-200009002-00007. View